212 related articles for article (PubMed ID: 11687616)
1. Meis1a suppresses differentiation by G-CSF and promotes proliferation by SCF: potential mechanisms of cooperativity with Hoxa9 in myeloid leukemia.
Calvo KR; Knoepfler PS; Sykes DB; Pasillas MP; Kamps MP
Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13120-5. PubMed ID: 11687616
[TBL] [Abstract][Full Text] [Related]
2. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
Calvo KR; Sykes DB; Pasillas MP; Kamps MP
Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
[TBL] [Abstract][Full Text] [Related]
3. Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression.
Calvo KR; Sykes DB; Pasillas M; Kamps MP
Mol Cell Biol; 2000 May; 20(9):3274-85. PubMed ID: 10757811
[TBL] [Abstract][Full Text] [Related]
4. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes.
Wang GG; Pasillas MP; Kamps MP
Mol Cell Biol; 2006 May; 26(10):3902-16. PubMed ID: 16648484
[TBL] [Abstract][Full Text] [Related]
5. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors.
DeKoter RP; Walsh JC; Singh H
EMBO J; 1998 Aug; 17(15):4456-68. PubMed ID: 9687512
[TBL] [Abstract][Full Text] [Related]
6. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus.
Wang GG; Pasillas MP; Kamps MP
Blood; 2005 Jul; 106(1):254-64. PubMed ID: 15755900
[TBL] [Abstract][Full Text] [Related]
7. Human recombinant stem cell factor stimulates in vitro proliferation of acute myeloid leukemia cells and expands the clonogenic cell pool.
Carlesso N; Pregno P; Bresso P; Gallo E; Pileri A; Zsebo KM; Ferrero D
Leukemia; 1992 Jul; 6(7):642-8. PubMed ID: 1378162
[TBL] [Abstract][Full Text] [Related]
8. Proliferative reaction of myelogenous leukemia cells with cytokines G-CSF, GM-CSF, M-CSF, SCF and TPO.
Murayama T; Imoto S; Natazuka T; Chihara K; Matsui T
Leuk Res; 1998 Jun; 22(6):557-60. PubMed ID: 9678722
[TBL] [Abstract][Full Text] [Related]
9. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
10. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
11. HoxB8 requires its Pbx-interaction motif to block differentiation of primary myeloid progenitors and of most cell line models of myeloid differentiation.
Knoepfler PS; Sykes DB; Pasillas M; Kamps MP
Oncogene; 2001 Sep; 20(39):5440-8. PubMed ID: 11571641
[TBL] [Abstract][Full Text] [Related]
12. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.
Bourette RP; Grasset MF; Mouchiroud G
Oncogene; 2007 Jan; 26(2):234-47. PubMed ID: 16819510
[TBL] [Abstract][Full Text] [Related]
13. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
[TBL] [Abstract][Full Text] [Related]
14. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b.
Kroon E; Krosl J; Thorsteinsdottir U; Baban S; Buchberg AM; Sauvageau G
EMBO J; 1998 Jul; 17(13):3714-25. PubMed ID: 9649441
[TBL] [Abstract][Full Text] [Related]
15. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
[TBL] [Abstract][Full Text] [Related]
16. Differential response to stem cell factor and Flt3 ligand by the FAB subtype in acute myeloid leukemia clonogenic cells.
Murohashi I; Yoshida K; Kishimoto K; Takahashi T; Wakao D; Jinnai I; Yagasaki F; Kawai N; Suzuki T; Matsuda A; Hirashima K; Bessho M
J Interferon Cytokine Res; 2002 Mar; 22(3):335-41. PubMed ID: 12034041
[TBL] [Abstract][Full Text] [Related]
17. HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo.
Fischbach NA; Rozenfeld S; Shen W; Fong S; Chrobak D; Ginzinger D; Kogan SC; Radhakrishnan A; Le Beau MM; Largman C; Lawrence HJ
Blood; 2005 Feb; 105(4):1456-66. PubMed ID: 15522959
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-regulated conditional oncoproteins: tools to address open questions in normal myeloid cell function, normal myeloid differentiation, and the genetic basis of differentiation arrest in myeloid leukemia.
Sykes DB; Kamps MP
Leuk Lymphoma; 2003 Jul; 44(7):1131-9. PubMed ID: 12916864
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of p55Cdc inhibits granulocyte differentiation and accelerates apoptosis in myeloid cells.
Kao CT; Lin M; O'Shea-Greenfield A; Weinstein J; Sakamoto KM
Oncogene; 1996 Sep; 13(6):1221-9. PubMed ID: 8808696
[TBL] [Abstract][Full Text] [Related]
20. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
